PofoliaShared via Pofolia

ACS Omega· 2026Q1

Effects of Tiger Tail Sea Cucumber Bohadschia argus on Wound Healing In Vitro and In Vivo Using an Acute Rat Model Infected with Staphylococcus aureus

Marianti A. Manggau, Muhammad Aris, Ariyani Buang, Frederika Tangdilintin et al.

Short summary

Topical application of 1% tiger tail sea cucumber (Bohadschia argus) extract (EEBA) significantly accelerated wound healing in a rat model infected with Staphylococcus aureus, showing reduced inflammation, enhanced fibroblast proliferation, and improved collagen organization.

AI-generated from the title and abstract; the full text is not read.

Key points

  • Ethanol extract of tiger tail sea cucumber (EEBA) showed antioxidant and anti-inflammatory activity in vitro.
  • Topical 1% EEBA accelerated wound healing and contraction in a rat model infected with Staphylococcus aureus.
  • Histological analysis of EEBA-treated wounds showed reduced inflammation, enhanced fibroblast proliferation, and improved collagen organization.
  • Molecular docking indicated potential interactions of EEBA compounds with inflammatory and bacterial targets (TNF-α, NF-κB, DNA gyrase-B, etc.).
  • EEBA exhibited good biocompatibility with <5% erythrocyte lysis.

AI-generated from the title and abstract; the full text is not read.

Abstract

Abstract Infectious wounds caused by Staphylococcus aureus remain a significant clinical challenge due to delayed healing and increasing antimicrobial resistance, necessitating alternative therapeutic strategies. This study aimed to evaluate the wound-healing potential of the ethanol extract of the tiger tail sea cucumber Bohadschia argus (EEBA) through integrated in vitro, in vivo, and in silico approaches. Phytochemical profiling using LC-HRMS identified 260 metabolites, and 12 prioritized compounds were selected for molecular docking analysis. EEBA demonstrated concentration-dependent antioxidant activity in the nitric oxide scavenging assay and inhibitory effects on protein denaturation, indicating anti-inflammatory potential, although differences compared to controls were not statistically significant (p > 0.05). In an excisional wound model in Staphylococcus aureus-infected Wistar rats, topical application of 1% EEBA accelerated wound contraction and improved macroscopic healing compared to the negative control. Histopathological evaluation revealed reduced inflammatory cell infiltration, enhanced fibroblast proliferation, increased angiogenesis, and improved collagen organization across the inflammatory, proliferative, and maturation phases. Hemolysis testing confirmed good biocompatibility with negligible erythrocyte lysis (<5%). Molecular docking demonstrated favorable binding affinities of selected compounds toward key inflammatory targets, including TNF-α, NF-κB, and FLAP, as well as antibacterial targets relevant to Staphylococcus aureus, namely, DNA gyrase-B, dihydrofolate reductase, and penicillin-binding protein. These findings provide preliminary mechanistic insights into the potential wound-healing and antibacterial activities of EEBA. Overall, EEBA exhibits promising wound-healing activity in an infected wound model through modulation of oxidative stress and inflammatory pathways, with selected metabolites also showing potential interactions with bacterial targets associated with S. aureus infection. These findings support the potential development of EEBA as a natural therapeutic candidate for infected wound management.

The authors' abstract, as published at the source. ACS Omega, 2026 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Rehabilitation

RehabilitationMedicine